DOCSLIB.ORG

The Medical Technology Sector

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Medical Technology Sector HEALTH MADE IN GERMANY The Medical Technology Sector 1 The Medical Technology secTor Summary The German medical technology sector is well positioned in international markets. It has estab- lished strong trading partnerships with health- care stakeholders across the globe and profits from increased demand worldwide. By combin- ing long-standing competences in engineering, manufacturing and healthcare, German companies are pioneers in the development of new medical devices and services. They provide state-of-the- art products that fulfill the highest quality and safety standards in accordance with international regulations. The industry also benefits from exceptional research facilities in the different health and engineering disciplines, optimal health- care infrastructure with internationally renowned hospitals, and excellent manufacturing standards. EUR 29.9 bn turnover generated by the German medical technolgy sector in 2017 1,300+ German manufacturers active in the medical technology sector 18.6% of German medical technology exports to North America in 2017 1,340 German medical technology patent applications in Europe in 2017 2 The Medical Technology Sector | health-made-in-germany.com Market Data The medical technology industry is a major pil- German Medical Technology Turnover* 2011 to 2017 lar within modern healthcare systems, providing in EUR billion innovative solutions for current challenges and needs. German companies enjoy global acclaim for their high-quality products and services, allowing Export turnover Domestic turnover Germany to consolidate its position as one of the 29.9 world’s leading healthcare providers. 29.2 27.6 19.1 25.4 18.6 24.6 The sector in Germany is largely made up of 24.1 17.6 23.2 family-owned small and medium-sized enter- 16.4 15.5 15.9 prises (SMEs) who are backed by tradition, 14.5 quality and high standardization. In 2017, the approximately 1,300 medical device manufactur- ers (>20 employees) and their 137,900 employees generated EUR 29.9 billion in total sales. This represents a continuous revenue growth com- 10.6 10.8 pared to previous years. The industry is strongly 10.0 9.0 commited to research and development (R&D). 8.7 8.6 8.7 Approximately nine percent of revenue is spent on R&D activities. The high degree of innova- tion in the German medical technology sector is further borne out by the fact that one third 2011 2012 2013 2014 2015 2016 2017 of turnover is generated from medical prod- Sources: SPECTARIS, German Federal Office of Statistics 2018 ucts that are just three years old or younger. *data refers to German medical technology companies with >20 employees Germany is second only to the United States in terms of medical technology patents filed at the This innovative spirit goes well beyond medical European Patent Office. technology companies active in the field of in- patient and out-patient healthcare, rehabilitation Excellent domestic R&D conditions have con- and prevention. Germany also has a solid base tributed to the formation of a diverse start-up of companies providing high-quality and innova- environment in Germany. Driven by regional tive processing, production and manufacturing governments, large companies and clinics, more services to clients in the medical technology than a dozen accelerators and local hubs support industry. the foundation of new medtech start-ups – most of them focusing on digital health solutions. These attributes are major reasons for the suc- cess of German medical technology companies in the global market. A large share of revenue is Top EU Medical Technology Industries generated from exports – Germany is the third- in EUR billion largest provider of medical technology services and products globally. The strongest demand National Industry Country arises from its nearest neighbors, with one third Turnover* of European medtech sales originating from Ger- Germany 32.39 man companies and almost half of all German medical technology exports going to other Euro- Ireland 11.62 pean countries. France 11.02 Germany is also a respected trading partner in Italy 9.51 North America and Asia, regions that account for approximately 19 percent of German exports United Kingdom 8.15 respectively. Emerging markets such as China and India have also helped revenue growth, providing Sources: Eurostat, SPECTARIS 2018 a solid base for German medical technology com- *referring to 2015 or latest available national sources; also includes small companies with <20 employees panies’ international expansion. 3 eMerging MarkeTs and digiTal healTh Industry Trends Growing Export Markets German Medical Technology Export Turnover Demand for modern healthcare infrastructure – by Country 2017 based on high-quality medical technology prod- in EUR billion ucts and standards – is rising across the globe thanks to increasing economic wealth and well- being as well as demographic change. The German 4.05 medical technology industry is excellently posi- tioned, enjoying specific export growth in Asian, African and Middle Eastern countries. One of the most important emerging markets is China where German companies generated sales of around EUR 1.75 billion in 2017, surpassed only by sales 1.75 of EUR 4 billion in the United States. Other rising 1.50 1.46 trading partners include Japan, India and certain 1.11 African countries. New regulatory frameworks for the approval or market entry of foreign medical products based on existing CE marks will stimu- USA China The Netherlands France Italy late further expansion in these markets. Sources: German Federal Office of Statistics, SPECTARIS 2018 Digital Health Know-how Advanced global health standards boost demand tools. Germany’s dynamic digital health land- for digital health products and telemedical scape is home to established corporations and devices. The disruptive nature of digital health start-ups alike, bringing together long-standing innovation is dramatically changing the structure IT expertise and high-level healthcare profes- of health systems worldwide, offering growth sionals in hospitals and clinics. The interlinking opportunities for digital health solutions in of in-patient and out-patient care is among the emerging countries. The German medical tech- major issues addressed, leading to the improve- nology industry provides a broad spectrum of ment for rehabilitation services and homecare. services in this field; be it medical imaging and Wearables, cloud computing, blockchain tech- diagnostics, IT-based medical information sys- nologies, artificial intelligence (AI) approaches, tems, video consultation, wearables to monitor deep learning tools, and virtual reality systems chronic diseases, cloud-based patient data stor- are all explored to help meet today’s healthcare ing or digital doctor-to-patient communication challenges. German Medical Technology Exports by Region 2017 in percent EU 41.9 North America 18.6 Asia 18.6 Rest of Europe 9.3 South and 3.4 Central America Sources: German Federal Office of Statistics, SPECTARIS 2018 4 The Medical Technology Sector | health-made-in-germany.com AI-based Medical Imaging Global Medical Device Sale by Application Area 2017 Germany offers strong clinical expertise and in USD billion world-class professionals in the fields of oncol- ogy, cardiology, neurology, diabetology, and infec- tious diseases. According to data published by the Cardiology 46.9 BVMed medical technology industry association, these indications belong to the top priority R&D Diagnostic 39.5 topics addressed by German businesses. Imaging Companies work closely together with university Orthopedics 36.5 hospitals and private clinics domestically and internationally. Fast and precise high-resolution medical imaging – such as magnet resonance Ophtalmics 27.7 imaging (MRI) – supporting diagnostic and treat- ment processes in hospitals is just one of the General & 22.1 strengths of the German medical technology Plastic Surgery industry. Large corporations, mid-sized compa- nies and start-ups adapt a number of innovative Endoscopy 18.5 approaches to provide more efficient products and services. AI-based systems are clearly at the top of the agenda for optimizing treatment Dental 13.9 outcomes for cancer and skin diseases. Other Wound applications focus on the further development of 13.0 preventive healthcare strategies. Management Engineering Excellence Healthcare IT 11.8 German excellence in engineering, processing and automation makes the country a hot spot for Diabetic Care 11.7 developing technically complex devices, machines and robotic- or sensor-based processes for use in Source: Evaluate Ltd. 2018 the medical technology industry. Specific com- petences exist in the development of completely new surgical operation systems with connected devices, thereby bringing IT-based infrastructure and innovative medical products together. German companies have an enviable reputation for producing and manufacturing high-quality materials adapted and intended for use in medi- cal products like implants and prostheses. Trends, such as 3D printing and innovative polymers, are explored in close cooperation with academic DIGITAL HEALTH SECTOR research institutes and start-ups. This provides novel functionalities and enhanced production A significant number of processes to medical technology industry clients. HEALTH MADE IN GERMANY companies in Germany The Digital Health Sector are developing digital health solutions. This publication gives an overview of the sector and provides partner links. 1 5 Broad ProducT and service sPecTruM
Load more

Recommended publications
  • Digitizing Healthcare – Opportunities for Germany
    Digitizing healthcare – opportunities for Germany Digitizing healthcare – opportunities for Germany Society is aging and healthcare costs keep rising. By digitizing the system, health services can be provided at lower cost and higher quality. A new study reveals the areas for and extent of potential improvements. Germany might be talking about it, but our neighbors are already one step ahead. Austria has ELGA – an electronic health record system – that can easily be accessed by any medical practi- tioner or hospital as necessary. Doctors in Sweden, Denmark, and Estonia send prescriptions electronically to the patient or straight to the pharmacy that delivers the medication. And Britain’s state-run NHS has partnered with Google to deploy artificial intelligence (AI) as a way to utilize the inordinately vast pool of data about successful treatments and disease progres- sions that the NHS has compiled over the years. Back in Germany, healthcare regulators, patients, payors, and providers are hoping that digitization will enable faster access to data. In addition, digitization holds the potential for massive bottom-line value. A McKinsey study prepared in partnership with the German Managed Care Association (BMC) suggests that up to EUR 34.0 billion in potential value could have been realized in 2018 if the German healthcare system had been fully digitized. This is equivalent to around 12 percent of its actual total projected costs of around EUR 290 billion this year, which is a record high. Trends continue unabated: on top of a nominal annual increase of 4.5 percent, Germany’s aging population and expensive treatment methods are driving the rise in health spending.
    [Show full text]
  • Psychiatry in Germany
    61 emotion and relapse in depressed patients. British Journal of Psy- Okasha, A., El Akabawi, A., Synder, K., et al (1994) Expressed emotion, chiatry, 148, 642–647. perceived criticism, and relapse in depression: a replication in an Leff, J. (1988) Psychiatry Around the Globe: A Transcultural View. Egyptian community. American Journal of Psychiatry, 151, 1001–1005. Gaskell. Ruiz, P. (ed.) (2000) Ethnicity and psychopharmacology. In Review of Mohit, A. (1999) Middle East culture: mental health and mental illness. Psychiatry. Volume 19 (eds J. Oldham & M. Riba). American Psychiatric In One World, One Language – Paving the Way to Better Perspectives Press. for Mental Health (eds J. Lopez-Ibor, F. Lieh-Mak, H. Visotsky, et al). United Nations Development Programme (2003) Human Development Hogrefe & Huber. Report. Available at http://www.undp.org (last accessed 17 April Montero, I., Gomez-Beneyto, M., Ruiz, I., et al (1992) The influence of 2007). family expressed emotion on the course of schizophrenia in a sample Vaughn, C. E. & Leff, J. P. (1976) The influence of family and social of Spanish patients. British Journal of Psychiatry, 161, 217–222. factors on the course of psychiatric illness: a comparison of schizo- Okasha, A. (ed.) (1988) Okasha’s Clinical Psychiatry. Anglo Egyptian phrenic and depressed neurotic patients. British Journal of Psychiatry, Bookshop. 129, 125–137. Okasha, A. (2000) The impact of Arab culture on psychiatric ethics. World Psychiatric Association (1996) Declaration of Madrid on Ethical In Ethics Culture and Psychiatry. International Perspectives (eds A. Standards for Psychiatric Practice. Approved by the General Assembly Okasha, J. Arboleda-Florez & N. Sartorius).
    [Show full text]
  • Value-Based Healthcare in Germany from Free Price-Setting to a Regulated Market
    A report from The Economist Intelligence Unit Value-based Healthcare in Germany From free price-setting to a regulated market SPONSORED BY: Value-based healthcare in Germany From free price-setting to a regulated market Contents About this report 2 Introduction 3 Chapter 1: The evolution of health technology assessment and pharmaceutical pricing reform 5 Chapter 2: New focus on providers and outcomes 9 Conclusion 13 © The Economist Intelligence Unit Limited 2015 1 Value-based healthcare in Germany From free price-setting to a regulated market About this report Value-based healthcare in Germany: From free and experience: price-setting to a regulated market is a report l Dr Clemens Guth, executive director, Artemed by The Economist Intelligence Unit (EIU), commissioned by Gilead Sciences. It looks at the l Dr Günther Jonitz, president, Berlin Chamber evolution of health technology assessment and of Physicians pharmaceutical pricing reform in Germany and l Dr Axel Mühlbacher, professor of health examines the new focus on providers and health economics and healthcare management, outcomes. Hochschule Neubrandenburg In July-August 2015 The EIU conducted l Dr Thorsten Schlomm, professor of urology four interviews with experts on value-based and member of faculty, Martini-Klinik healthcare in Germany, including senior The EIU bears sole responsibility for the content healthcare executives and practitioners as well of this report. The findings and views expressed as academics. The insights from these in-depth in the report do not necessarily reflect the views interviews appear throughout the report. The of the sponsor. Andrea Chipman was the author of EIU would like to thank the following individuals the report, and Martin Koehring was the editor.
    [Show full text]
  • The Nordic Model and British Public Policy C.1997-2015
    The Nordic model and British public policy c.1997-2015: social democratic mythology or free-market supermodel? Thesis submitted to the degree of Doctor of Philosophy at University College London by Thomas Hoctor Supervisors: Examiners: Mary Hilson Titus Hjelm Richard Mole J. Magnus Ryner 1 Declaration I, Thomas Hoctor confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. 2 Contents Acknowledgements ........................................................................................................... 8 Abstract ............................................................................................................................ 9 Introduction .................................................................................................................... 10 0.1 Britain votes leave .............................................................................................................. 10 0.2 Models, identity, branding .................................................................................................. 12 0.3 This study and its aims ........................................................................................................ 17 Chapter One – The Nordic Model: What is it and why does it matter? ............................. 22 1.1 Introduction ....................................................................................................................... 22 1.2. What is the Nordic
    [Show full text]
  • Can People Afford to Pay for Health Care? Germany
    Can people afford to pay for health care? New evidence Martin Siegel on financial protection Reinhard Busse in Germany Germany WHO Barcelona Office 2 for Health Systems Strengthening The WHO Barcelona Office is a centre of excellence in health financing for universal health coverage (UHC). It works with Member States across WHO’s European Region to promote evidence-informed policy making. A key part of the work of the Office is to assess country and regional progress towards UHC by monitoring financial protection – the impact of out-of-pocket payments for health on living standards and poverty. Financial protection is a core dimension of health system performance and an indicator for the Sustainable Development Goals. The Office supports countries to develop policy, monitor progress and design reforms through a combination of health system problem diagnosis, analysis of country-specific policy options, high-level policy dialogue and the sharing of international experience. It is also the home for WHO training courses on health financing and health systems strengthening for better health outcomes. Established in 1999, the Office is supported by the Government of the Autonomous Community of Catalonia, Spain. It is part of the Division of Health Systems and Public Health of the WHO Regional Office for Europe. © Foto: Robert Ramos/FPHSP Can people afford to pay for health care? New evidence on financial protection in Germany Written by: Martin Siegel Reinhard Busse Edited by: Pooja Yerramilli Sarah Thomson Series editors: Sarah Thomson Jonathan Cylus Tamás Evetovits ii Abstract & keywords This review is part of a series of country-based studies generating new evidence on financial protection in European health systems.
    [Show full text]
  • The Hazards of Harassing Doctors: Regulation and Reaction
    Table of Contents Introduction 2 By Frederick K. Goodwin, MD Uncle Sam, M.D.? 6 By Peter Pitts The Hazards of Harassing Doctors 8 Regulation and Reaction in European Healthcare 8 By Alphonse Crespo Introduction 9 Physicians and Authoritarianism in History 9 Downgrading Swiss Care by State Planning and Decree 11 French Tampering with Doctor Demography and Liberty 14 Mutiny in Germany and Beyond 16 The Road to Empowerment 18 Conclusion 20 The Virtual House Call 21 By Marc Siegel Are We Still the Best and Brightest? 21 The Virtual House Call 27 The Actual House Call 35 About the Authors 39 Introduction William Osler, generally regarded as the father of modern medicine wrote "If you listen carefully to the patient they will tell you the diagnosis." Arriving at a diagnosis and appropriate treatment plan has always represented collaboration between individual patients and their personal physician. But today physicians are increasingly seeing the decisions that they and their individual patient reach about a specific treatment plan second guessed by distant “third parties” (working for government or insurance bureaucracies) who, of course do not –indeed cannot- know the physician or the unique individual circumstances of a particular patient. Lacking any knowledge of the patient or the doctor, these bureaucrats must fall back on general “guidelines” as the basis for approval or rejection of a particular treatment. Having served on guideline development bodies I can tell you that, at best, they represent the kind of “lowest common denominator” conclusions necessary to get the many different opinions represented on a committee to coalesce into a consensus.
    [Show full text]
  • Country Profile: Germany Country Profile: Germany
    COUNTRY PROFILE: GERMANY COUNTRY PROFILE: GERMANY The healthcare system in Germany is made up of both public and private insurances and dates back to the 1880s, making it the oldest in Europe. The country’s universal, multi-payer healthcare system includes both statutory health insurance for people who earn less than a certain salary, as well as private health insurance for those who earn more and choose to purchase their own. Health insurance is required for the whole population in Germany. Employees and salaried workers who earn less than €60,750 per year are automatically enrolled into one of the nearly 130 public, non-profi t insurance collectives. Healthcare is funded by mandated contributions from employers and their employees through premiums. All workers contribute about 7.5 percent of their salary into a public health insurance pool. Employers match that 7.5 percent contribution. These contributions also cover dependents such as nonearning spouses and children. In addition to the mandated health insurance, which covers the majority of residents, those with a yearly income exceeding €60,750—as well as students and civil servants—can opt for private health insurance to replace or complement the public option. Germany has long had the most restriction-free and consumer-oriented healthcare system in Europe. Patients can seek almost any type of care they wish whenever they want it. Co-payments, which exist for medicines and other items are relatively low compared to other countries. The total out-of-pocket costs for medications are capped at two percent of an individual's income, and one percent of income for people with chronic diseases.
    [Show full text]
  • Benchmarking – German Report Document Produced by Sport Structures Ltd
    Benchmarking – German Report Document produced by Sport Structures Ltd Sport Structures Ltd, Company Number 4492940 PO Box 10710, Sutton Coldfield, B75 5YG (t): +44(0)845 241 7195 (m): +44(0)7766 768 474 (f): +44(0)845 241 7197 (e): [email protected] (w): www.sportstructures.com Sport Structures Ltd September 2011 Introduction ................................................................................................................................................................................................ 4 1 Country characteristics ................................................................................................................................................................... 5 1.1 Demographic structure ................................................................................................................................................................... 5 1.2 Health indicators ............................................................................................................................................................................ 5 1.3 Sports participation ........................................................................................................................................................................ 6 1.4 Sports success ............................................................................................................................................................................... 6 1.5 Sports/GDP ...................................................................................................................................................................................
    [Show full text]
  • Health and Healthcare Utilization Among Asylum-Seekers from Berlin’S LGBTIQ Shelter: Preliminary Results of a Survey
    International Journal of Environmental Research and Public Health Communication Health and Healthcare Utilization among Asylum-Seekers from Berlin’s LGBTIQ Shelter: Preliminary Results of a Survey Nora Gottlieb 1,* , Conny Püschmann 2, Fabian Stenzinger 2, Julia Koelber 2, Laurette Rasch 2, Martha Koppelow 2 and Razan Al Munjid 2 1 Department of Health Care Management, Technical University Berlin, 10623 Berlin, Germany 2 Berlin School of Public Health, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany; [email protected] (C.P.); [email protected] (F.S.); [email protected] (J.K.); [email protected] (L.R.); [email protected] (M.K.); [email protected] (R.A.M.) * Correspondence: [email protected]; Tel.: +49-(0)30-314-29222 Received: 9 June 2020; Accepted: 19 June 2020; Published: 23 June 2020 Abstract: Background: LGBTIQ asylum-seekers face multiple health risks. Yet, little is known about their healthcare needs. In 2016, Berlin opened the only major shelter for LGBTIQ asylum-seekers in Germany. This preliminary study describes health and healthcare utilization by asylum-seekers living in Berlin’s LGBTIQ shelter. To identify particular healthcare needs, we compared our results to asylum-seekers from other shelters. Methods: We surveyed residents of the LGBTIQ shelter and 21 randomly selected shelters in Berlin, using a validated questionnaire in nine languages (n = 309 respondents, including 32 respondents from the LGBTIQ shelter). Bivariate tests and generalized linear mixed models were applied to examine differences in health and healthcare utilization between the two groups. Results: Residents of the LGBTIQ shelter show high rates of chronic and mental illness.
    [Show full text]
  • Migrant Workers in the German Health Sector
    WORKPLACE INTEGRATION OF MIGRANT HEALTH WORKERS IN GERMANY Qualitative findings on experiences in two Hamburg hospitals Vesela Kovacheva Mareike Grewe July 2015 Co-funded by the European Union This project has been funded with support from the European Commission. This publication reflects the views only of the author, and the European Commission cannot be held responsible for any use which may be made of the information contained therein. iii Table of contents 1. Introduction ..................................................................................................................................................... 6 1.1 General design and research objectives .................................................................................................. 6 1.2 Migrant workers in the German health sector ........................................................................................... 7 2. Methodology .................................................................................................................................................... 9 2.1 Field work ................................................................................................................................................. 9 Table 1 Migrant population in Germany and Hamburg in 2013 .................................................................. 9 Figure 1 Share of foreign nationals in employees subject to social security contributions in 2011, by occupation .................................................................................................................................................10
    [Show full text]
  • The Medical Technology Industry in Germany
    INDUSTRY OVERVIEW The Medical Technology Industry in Germany ISSUE 2020 MEDICAL TECHNOLOGY IN GERMANY Europe’s Biggest Health- care Market “Germany is an extremely important market for Aerogen, and we look forward to continuing to strengthen our commitment here. With an in-country office, and an experienced team we are working closely with our customers and partners to meet their individual needs and grow together.” John Power CEO and Founder | Aerogen EUR 30 bn 2/3 sales generated by Germany’s medical of medical technology sales in export technology industry in 2018 markets in 2018 EUR 387 bn EUR 60 bn total annual health expenditure in 2018 – domestic out-of-pocket healthcare more than 11% of GDP market in 2018 ~100% 88% of Germany’s 82 million residents are covered of Germans are enrolled in a public health by health insurance insurance plan Global demand for innovative medical technology Domestically, more than 99 percent of the country’s 82 million solutions continues to grow as we live longer, healthier residents are covered by health insurance. German health lives. “Medical devices made in Germany” make a signi- insurers cover around two thirds of Germany’s total annual ficant contribution to enhancing patient health care and health spend of EUR 387 billion (or 11.4 percent of GDP). The quality of life around the world. Medical devices devel- out-of-pocket market is worth around EUR 60 billion. oped in Germany benefit from a world-class research and business environment, with the sector’s predominantly With its state-of-the-art infrastructure and its central small and medium-sized companies enjoying an inter- location in Europe, Germany is also an ideal location for national reputation as innovators and market leaders.
    [Show full text]
  • Forschungsbericht 2020
    Forschungsbericht 2020 Medizinische Fakult¨at MEDIZINISCHE FAKULTÄT Leipziger Str. 44, 39120 Magdeburg Tel. 49 (0)391 67 157 50, Fax 49 (0)391 67 157 49 1. LEITUNG Prof. Dr. rer. nat. Daniela C. Dieterich (Dekanin und Vorstandsvorsitzende) Prof. Dr. med. M. Pech (Prodekan fur¨ Struktur) Prof. Dr. med. Thomas Frodl (Studiendekan) Prof. Dr. med. Th. Tuting¨ (Prodekan fur¨ Forschung) Prof. Dr. med. R. Croner (Prodekan fur¨ Klinische Angelegenheiten) 2. INSTITUTE Institut fur¨ Anatomie Institut fur¨ Physiologie Institut fur¨ Medizinische Psychologie Institut fur¨ Biochemie und Zellbiologie Institut fur¨ Inflammation und Neurodegeneration Institut fur¨ Molekularbiologie und Medizinische Chemie Institut fur¨ Pharmakologie und Toxikologie Institut fur¨ Klinische Pharmakologie Institut fur¨ Sozialmedizin und Gesundheits¨okonomie Lehrbereich Geschichte, Ethik und Theorie der Medizin Institut fur¨ Allgemeinmedizin Institut fur¨ Biometrie und Medizinische Informatik Bereich Arbeitsmedizin Institut fur¨ Klinische Chemie und Pathobiochemie Bereich Klinische Chemie Bereich Pathologische Biochemie Institut fur¨ Pathologie Institut fur¨ Neuropathologie Rechtsmedizin Institut fur¨ Medizinische Mikrobiologie und Krankenhaushygiene Institut fur¨ Molekulare und Klinische Immunologie Institut fur¨ Transfusionsmedizin und Immunh¨amatologie mit Blutbank Institut fur¨ Humangenetik Institut fur¨ Kognitive Neurologie und Demenzforschung Institut fur¨ Experimentelle Innere Medizin Universit¨atsklinik fur¨ Neuroradiologie Universit¨atsklinik fur¨ Allgemein-, Viszeral-
    [Show full text]